https://www.selleckchem.com/products/ABT-263.html
bosis. We call for more studies elucidating the role that immunothrombosis might be playing in patients with COVID-19. The COVID-19 pandemic has spread worldwide and poses a severe health risk. While most patients present mild symptoms, descending pneumonia can lead to severe respiratory insufficiency. Up to 50% of patients show gastrointestinal symptoms like diarrhea or nausea, intriguingly associating with prolonged symptoms and increased severity. Thus, models to understand and validate drug efficiency in the gut of COVID-19 patients
Like
Comment
Share
